Health
Synthetic Nanobodies Identified That Neutralize SARS-CoV-2 – Anti Aging News
ACE2 has become the key target of COVID-19 therapeutics investigating interrupting the interaction between the spike protein on the SARS-CoV-2 virus and its receptor…
ACE2 has become the key target of COVID-19 therapeutics investigating interrupting the interaction between the spike protein on the SARS-CoV-2 virus and its receptor on host cells; recent work published in Nature Communications suggests that a synthetic nanobody, sybodies, has been found that can neutralize SARS-CoV-2 constituting a potential treatment. The group of researchers are reporting the rapid isolation and characterization of nanobodies from a synthetic library called sybodies that target…
-
Noosa News7 hours agoHow Lily Steele-Park took her rapist to court and won
-
General21 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Business12 hours agoFord CEO makes stunning prediction about artificial intelligence
-
Business22 hours ago5 amazing ASX ETFs for Aussie investors in July